Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
0.2%
operating margin TTM
9.79%
revenue TTM
3.09 Billion
revenue per share TTM
9.82$
valuation ratios | |
|---|---|
| pe ratio | 784.36 |
| peg ratio | 9.90 |
| price to book ratio | -42.28 |
| price to sales ratio | 1.58 |
| enterprise value multiple | 3.86 |
| price fair value | -42.28 |
profitability ratios | |
|---|---|
| gross profit margin | 36.76% |
| operating profit margin | 9.79% |
| pretax profit margin | 2.34% |
| net profit margin | 0.2% |
| return on assets | 0.16% |
| return on equity | -5.1% |
| return on capital employed | 10.5% |
liquidity ratios | |
|---|---|
| current ratio | 2.13 |
| quick ratio | 1.42 |
| cash ratio | 0.23 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 120.85 |
| operating cycle | 235.78 |
| days of payables outstanding | 52.38 |
| cash conversion cycle | 183.39 |
| receivables turnover | 3.18 |
| payables turnover | 6.97 |
| inventory turnover | 3.02 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.75 |
| debt equity ratio | -24.54 |
| long term debt to capitalization | 1.04 |
| total debt to capitalization | 1.04 |
| interest coverage | 1.17 |
| cash flow to debt ratio | 0.12 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.78 |
| cash per share | 0.64 |
| operating cash flow per share | 1.04 |
| free cash flow operating cash flow ratio | 0.75 |
| cash flow coverage ratios | 0.12 |
| short term coverage ratios | 45.51 |
| capital expenditure coverage ratio | 3.95 |
Frequently Asked Questions
When was the last time Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) reported earnings?
Amneal Pharmaceuticals, Inc. (AMRX) published its most recent earnings results on 06-11-2025.
What is Amneal Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)'s trailing twelve months ROE is -5.1%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Amneal Pharmaceuticals, Inc. (AMRX) currently has a ROA of 0.16%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did AMRX's net profit margin stand at?
AMRX reported a profit margin of 0.2% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is AMRX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.13 in the most recent quarter. The quick ratio stood at 1.42, with a Debt/Eq ratio of -24.54.